128 related articles for article (PubMed ID: 15198532)
1. Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution.
Young TJ; Johnson KP; Pace GW; Mishra AK
AAPS PharmSciTech; 2004 Feb; 5(1):E11. PubMed ID: 15198532
[TBL] [Abstract][Full Text] [Related]
2. Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs.
Young TJ; Mawson S; Johnston KP; Henriksen IB; Pace GW; Mishra AK
Biotechnol Prog; 2000; 16(3):402-7. PubMed ID: 10835242
[TBL] [Abstract][Full Text] [Related]
3. Stabilized nanoparticles of phytosterol by rapid expansion from supercritical solution into aqueous solution.
Türk M; Lietzow R
AAPS PharmSciTech; 2004 Sep; 5(4):e56. PubMed ID: 15760053
[TBL] [Abstract][Full Text] [Related]
4. A combinational supercritical CO2 system for nanoparticle preparation of indomethacin.
Tozuka Y; Miyazaki Y; Takeuchi H
Int J Pharm; 2010 Feb; 386(1-2):243-8. PubMed ID: 19895877
[TBL] [Abstract][Full Text] [Related]
5. Nanosizing drug particles in supercritical fluid processing.
Pathak P; Meziani MJ; Desai T; Sun YP
J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
[TBL] [Abstract][Full Text] [Related]
6. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
Thakur R; Gupta RB
Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
[TBL] [Abstract][Full Text] [Related]
7. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution.
Chen X; Young TJ; Sarkari M; Williams RO; Johnston KP
Int J Pharm; 2002 Aug; 242(1-2):3-14. PubMed ID: 12176220
[TBL] [Abstract][Full Text] [Related]
8. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.
Guada M; Sebastián V; Irusta S; Feijoó E; Dios-Viéitez Mdel C; Blanco-Prieto MJ
Int J Nanomedicine; 2015; 10():6541-53. PubMed ID: 26527872
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.
Yamasaki K; Kwok PC; Fukushige K; Prud'homme RK; Chan HK
Int J Pharm; 2011 Nov; 420(1):34-42. PubMed ID: 21864662
[TBL] [Abstract][Full Text] [Related]
13. Stable colloidal dispersions of a lipase-perfluoropolyether complex in liquid and supercritical carbon dioxide.
Adkins SS; Hobbs HR; Benaissi K; Johnston KP; Poliakoff M; Thomas NR
J Phys Chem B; 2008 Apr; 112(15):4760-9. PubMed ID: 18363394
[TBL] [Abstract][Full Text] [Related]
14. Production of cromolyn sodium microparticles for aerosol delivery by supercritical assisted atomization.
Reverchon E; Adami R; Caputo G
AAPS PharmSciTech; 2007 Dec; 8(4):E114. PubMed ID: 18181535
[TBL] [Abstract][Full Text] [Related]
15. A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
Lallemand F; Perottet P; Felt-Baeyens O; Kloeti W; Philippoz F; Marfurt J; Besseghir K; Gurny R
Eur J Pharm Sci; 2005 Sep; 26(1):124-9. PubMed ID: 15978789
[TBL] [Abstract][Full Text] [Related]
16. Interfacial properties of emulsions stabilized with surfactant and nonsurfactant coated boehmite nanoparticles.
Tigges B; Dederichs T; Möller M; Liu T; Richtering W; Weichold O
Langmuir; 2010 Dec; 26(23):17913-8. PubMed ID: 21028858
[TBL] [Abstract][Full Text] [Related]
17. Griseofulvin micronization and dissolution rate improvement by supercritical assisted atomization.
Reverchon E; Della Porta G; Spada A; Antonacci A
J Pharm Pharmacol; 2004 Nov; 56(11):1379-87. PubMed ID: 15525444
[TBL] [Abstract][Full Text] [Related]
18. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
[TBL] [Abstract][Full Text] [Related]
19. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
20. Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
Wolska E; Sznitowska M
Int J Pharm; 2013 Jan; 441(1-2):449-57. PubMed ID: 23164704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
